PBC
- A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Biliary Cholangitis (VANTAGE)
- Seladelpar in Subjects With Primary Biliary Cholangitis (PBC)
- Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) (ELATIVE)
- A Trial of Setanaxib in Patients With Primary Biliary Cholangitis (PBC) and Liver Stiffness (TRANSFORM)
- Global Linerixibat Itch Study of Efficacy and Safety in Primary Biliary Cholangitis (PBC) (GLISTEN)
- Linerixibat Long-term Safety, and Tolerability Study (LLSAT)
Disclaimer
Trials are subject to periodic re-evaluations that may shorten or extend the enrolment period, regardless of the investigator’s preference. In addition, enrolment in trials is assessed at the trial centre according to strict inclusion and exclusion criteria designed to maximise patient safety and the completeness and reliability of the data collected.